ENDOR AG/ DE0005491666 /
| 2024-05-08 9:00:49 AM | Chg. +0.070 | Volume | Bid9:06:14 AM | Ask9:06:14 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.140EUR | +6.54% | 8,634 Turnover: 9,953.440 |
1.020Bid Size: 5,000 | 1.150Ask Size: 3,665 | 17.98 mill.EUR | - | 5.80 |
GlobeNewswire
03-28
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
2020-05-01
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
2020-04-28
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.
GlobeNewswire
2020-04-24
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
2020-04-17
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Inv...
GlobeNewswire
2020-03-02
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business ...
GlobeNewswire
2020-01-16
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
GlobeNewswire
2020-01-16
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
